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Background: Type 2 diabetes (T2D) and cardiovascular disease (CVD) are leading
causes of mortality and two of the most costly diet-related ailments worldwide.
Consumption of fiber-rich diets has been repeatedly associated with favorable impacts
on these co-epidemics, however, the healthcare cost-related economic value of altered
dietary fiber intakes remains poorly understood. In this study, we estimated the annual
cost savings accruing to the Canadian healthcare system in association with reductions
in T2D and CVD rates, separately, following increased intakes of dietary fiber by adults.
Methods: A three-step cost-of-illness analysis was conducted to identify the
percentage of individuals expected to consume fiber-rich diets in Canada, estimate
increased fiber intakes in relation to T2D and CVD reduction rates, and independently
assess the potential annual savings in healthcare costs associated with the reductions
in rates of these two epidemics. The economic model employed a sensitivity analysis of
four scenarios (universal, optimistic, pessimistic, and very pessimistic) to cover a range
of assumptions within each step.
Results: Non-trivial healthcare and related savings of CAD$35.9-$718.8 million in
T2D costs and CAD$64.8 million–$1.3 billion in CVD costs were calculated under a
scenario where cereal fiber was used to increase current intakes of dietary fiber to the
recommended levels of 38 g per day for men and 25 g per day for women. Each 1 g per
day increase in fiber consumption resulted in annual CAD$2.6 to $51.1 million savings
for T2D and $4.6 to $92.1 million savings for CVD.
Conclusion: Findings of this analysis shed light on the economic value of optimal
dietary fiber intakes. Strategies to increase consumers’ general knowledge of the
recommended intakes of dietary fiber, as part of healthy diet, and to facilitate stakeholder
synergy are warranted to enable better management of healthcare and related costs
associated with T2D and CVD in Canada.
Keywords: fiber consumption, type 2 diabetes, cardiovascular disease, economic benefits, healthcare cost
saving, nutrition economics, public health
Abbreviations: CIHI, Canadian Institute for Health Information; CVD, cardiovascular disease; EBIC, Economic Burden of
Illness in Canada; IOM, Institute of Medicine; NHEX, National Health Expenditure Trends; T2D, type 2 diabetes.
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Introduction
Globally, the growing prevalence of type 2 diabetes (T2D)
and CVD has been accompanied by escalating costs related
to healthcare and society’s loss of productivity, putting these
two diet-related epidemics among the world’s top public health
policy priorities. Approximately 9% of adults around the world
were diagnosed with diabetes in World Health Organization
(2014), of which 90% had T2D, together with 4.9 million
deaths and diabetes-related costs that reached US$612 billion.
In Canada, the prevalence of diagnosed diabetes increased by
70% between 1998/99 and 2008/09 (Public Health Agency of
Canada, 2011), with a conservative total cost estimate of CAD$2.5
billion (excluding costs of complications) in 2000 and total direct
healthcare costs projected to increase to over CAD$8 billion
annually by 2016 (Ohinmaa et al., 2004). Similar trends have
been observed for costs related to CVD, which accounted for over
30% of all deaths (17 million) worldwide in 2008 (World Health
Organization, 2011). The global economic burden associatedwith
the disease management costs of CVD was estimated to reach
US$863 billion in 2010 and is projected to exceed 1 trillion by
2030 (World Health Organization, 2011). In Canada, 29% of all
deaths in 2008 were secondary to CVD, which was estimated to
cost upward of CAD$21 billion in annual healthcare expenditures
(Conference Board of Canada, 2010).
Dietary behaviors consistent with guidelines for healthy eating
have the potential to produce substantial health and economic
beneﬁts. Previous research has demonstrated that, for example,
increased consumption of dairy, as well as reduced intakes of
calories, sodium, and saturated fat would facilitate considerable
health and economic beneﬁts ranging from US$2 to $58 billion
annually (McCarron and Heaney, 2004; Dall et al., 2009; Bibbins-
Domingo et al., 2010). From a functional food perspective, Gyles
et al. (2010) showed that direct and indirect coronary heart
disease (CHD)-related costs could be reduced by CAD$38million
to $2.5 billion if Canadians increased intakes of phystosterols.
More recently, Schmier et al. (2014, 2015) modeled the potential
for substantial constipation-related savings in healthcare costs
in the US and Europe from increased consumption of dietary
ﬁber.
In Canada, the deﬁnition of dietary ﬁber includes
carbohydrates that naturally occur in foods of plant origin
and are not digested or absorbed by the small intestine of
humans (Health Canada, 2012a). Among other disorders, dietary
ﬁber has been associated with meaningfully lower prevalence
of T2D and CVD (Merchant et al., 2003; Kendall et al., 2010;
Chen et al., 2013). For instance, a meta-analysis of ﬁve cohorts
(n = 239,485) showed a 19% lower risk of diabetes (RR = 0.81,
95% CI 0.70–0.93) among individuals in the highest quintile
of dietary ﬁber intake (Anderson and Conley, 2007). Similarly,
analysis of seven cohorts (n = 158,327) demonstrated that,
compared to the lowest quintile of ﬁber intake, the highest levels
of dietary ﬁber reduced risk of CHD by 29% (RR = 0.71, 95%
CI 0.47–0.95; Anderson, 2004). Further systematic analysis of
the available evidence has suggested that, compared to fruit or
vegetable-derived ﬁber, diets with higher levels of ﬁber from
cereals are associated with the greatest reduction in risk for
T2D (Cho et al., 2013; InterAct Consortium, 2015) and CVD
(Mozaﬀarian et al., 2003; Threapleton et al., 2013).
The average level of ﬁber consumed by Canadians is estimated
to be 19.1 and 15.6 g per day for males and females, respectively
(Belanger et al., 2014), and are well-below the IOM recommended
adequate intakes for males (38 g per day) and females (25 g
per day) between 19 and 50 years of age (Institute of Medicine,
2002). Sources of dietary ﬁber within the Canadian food supply
are plentiful as both whole foods and ﬁber-fortiﬁed foods.
Additionally, the Canadian population already has the necessary
tools available in the marketplace to enact behavioral changes
that would be consistent with increased intakes of dietary ﬁber.
However, ﬁber education and motivation remain as long-term
dietary challenges to consciously increase the consumption of
ﬁber in Canada.
Given Canada’s publically funded healthcare system, the
promotion of dietary strategies that facilitate meaningful
reductions in healthcare costs and prolong economic
productivity can be considered a powerful tool for healthcare
practitioners and policymakers attempting to manage economic
resources. In this regard, the potential economic impact of
increasing Canadians’ ﬁber consumption can be calculated by
determining the proportion of the economic burden related
to T2D and CVD that can be avoided by increasing the
consumption of dietary cereal ﬁber. Thus, the objective of
this study was to evaluate the potential economic beneﬁts
of increased intakes of dietary cereal ﬁber for adults as
determined by consequence reductions in annual healthcare
costs associated with independently reduced rates of T2D and
CVD in Canada.
Materials and Methods
Study Design
Utilizing data from the current medical literature and recent
healthcare cost estimates from national databases, a three-step
variation of a cost-of-illness analysis was conducted to evaluate
the healthcare-related economic beneﬁts of ﬁber consumption:
(i) Determination of the success rate, which represents the
proportion of the Canadian population expected to consume
ﬁber-rich diets, (ii) Independent analysis of the T2D and CVD
reduction rates that would result from consumption of dietary
ﬁber, and (iii) Estimation of the healthcare cost savings associated
with reductions in T2D and CVD rates. Additionally, a sensitivity
analysis of four scenarios (universal, optimistic, pessimistic, and
very pessimistic) was created to cover a range of predictions
within each of these steps.
Overall, three diﬀerent sets of analyses were completed. The
ﬁrst analysis reﬂected the cost reductions in T2D and CVD-
related healthcare services when cereal ﬁber is utilized to increase
current actual intakes of dietary ﬁber for Canadian men (19.1 g
per day) and women (15.6 g per day; Belanger et al., 2014) to
the IOM’s adequate intakes of 38 g per day and 25 g per day
for men and women, respectively (Institute of Medicine, 2002).
These are the cut-oﬀ values that policy makers, dietitians, and
other healthcare providers in Canada and the US typically use
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as guidelines. The second analysis examined the healthcare cost
savings per g increase in cereal ﬁber intake. The third analysis
estimated the total dollar savings at incremental levels of 20, 25,
30, and 35 g ﬁber per day for men and women alike, reﬂecting a
moderate stepwise increase in cereal ﬁber consumption. Table 1
summarizes the input parameters of the model. This analysis
was applied to Canadian adults, which were deﬁned as men
and women ≥18 years of age. Demographic populace data was
from 2014 and attained from Statistics Canada (Statistics Canada,
2015).
Step 1 of the Cost-of-Illness Analysis:
Assessing the Success Rate
In economic theory, individuals make choices to maximize
their utility, an unobservable metric for the satisfaction they
receive from consuming goods or receiving services, subject
to the constraints of time and ﬁnancial resources. Previous
research has explored how consumers maximize their utility
in the context of food, nutrition, and health [Grossman (1972,
March–April); Blaylock et al., 1999; Cawley, 2004]. More recent
work (Lioutas, 2014) has examined the information processing
behavior that consumers utilize as it relates to food choices.When
an individual processes available dietary information and, based
on this information, chooses to purchase and consume “healthy”
foods, the individual is maximizing their utility. If this behavior
is sustained over a period of time, the consumer may experience
a health improvement.
The eventual economic beneﬁt of increased dietary ﬁber
intake is dependent on individual consumer decisions within
the marketplace. Therefore, any model which attempts to
measure the potential public health beneﬁts should start with
an examination of consumer behavior. A key assumption in
health psychology and economics is that behavioral changes are
the result of a decision-making process, where the beneﬁts and
costs of particular changes are considered before the adoption
TABLE 1 | Summary of the input parameters for the cost saving
assessment model.
Parameter Men Women Source
Current fiber intake, g per day 19.1 15.6 Belanger et al.
(2014)
Target fiber intake, g per day
38 25 Institute of
Medicine (2002)
20
25
30
35
20
25
30
35
Assumption for the
economic valuation
of incremental
increases in intake
20.1 16.6 Assumption for
economic valuation
of a per g increase
in intake
T2D reduction per 1 g cereal
fiber intake, %
2.5 2.5 InterAct
Consortium (2015)
CVD reduction per 1 g cereal
fiber intake, %
1.1 1.1 Threapleton et al.
(2013)
CVD, cardiovascular disease; IOM, Institute of Medicine; T2D, type 2 diabetes.
of a speciﬁc course of action. In previous short-term research
that assessed consumer behavior in relation to dietary ﬁber
intakes and health claims, ﬁber was found to be viewed favorably
(Mialon et al., 2002; Dean et al., 2007; Baixauli et al., 2009;
Ginon et al., 2009; Tudoran et al., 2009). For instance, when
grain products were labeled as high in ﬁber and provided to
consumers, enhanced likelihood of consumption (Mialon et al.,
2002) as well as higher acceptability and purchase intentions
(Baixauli et al., 2009) were reported. However, the actual long-
term intake behavior for dietary ﬁber has not been previously
measured. As such, in order to estimate the percent of the
population expected to adopt a ﬁber-rich diet in Canada, a
sensitivity analysis of universal, optimistic, pessimistic, and very
pessimistic success rate scenarios was modeled based on ﬁndings
from previous research (Mialon et al., 2002; Dean et al., 2007;
Baixauli et al., 2009; Ginon et al., 2009; Tudoran et al., 2009).
The universal fortiﬁcation scenario assumed a 100% success
rate and represented a dramatic shift in the dietary habits of
Canadians. While this scenario is not realistically achievable in
the short-term, it represents the maximum potential of economic
savings with increased ﬁber intake over the very long-term. The
optimistic success rate was assumed to be 50%, and represented
a medium- to short-term pragmatic estimate of the potential
economic savings possible through an increased dietary ﬁber
intake. The pessimistic and very pessimistic success rates were
set at 15% and 5% to respectively represent a less positive (but
practical) short-to-medium term estimate of economic savings
following increased ﬁber intake, and determine the impact on
the cost estimates when assumptions are more pessimistic than
normal.
Step 2 of the Cost-of-Illness Analysis:
Estimating Disease Reduction due to
Increased Dietary Cereal Fiber Intake
Several epidemiological and dietary intervention studies of
diﬀerent designs have documented beneﬁcial impacts of
increased dietary ﬁber intake on disease risk and mortality
rates. Similar to Step 1 of this analysis, we established possible
scenarios regarding reductions in the incidence of T2D and
CVD with higher intakes of dietary ﬁber based on the current
English-language medical and nutritional literature. After careful
examination of the available literature, model assumptions were
generated based on two recent comprehensive systematic meta-
analyses by Threapleton et al. (2013) and InterAct Consortium
(2015). Eligibility criteria and quality of studies are included in
the meta-analyses of choice. Under the context of this study
and the studies reviewed, cereal ﬁber refers to ﬁber from cereal
grains.
Estimated Effect of Increased Dietary Cereal Fiber on
Prevalence of Type 2 Diabetes
The inverse relationship between increased dietary ﬁber and rates
of T2D risk were estimated from a meta-analysis by InterAct
Consortium (2015) based on data from prospective studies,
where a per 10 g increase in cereal ﬁber resulted in an average of
25% reduced risk of T2D (RR = 0.75, 95% CI 0.65–0.86). These
results are corroborated by a previous systematic review by Cho
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et al. (2013), where cereal ﬁber consumption was estimated to
decrease the risk of T2D by 18–40%.
Estimated Effect of Increased Dietary Cereal Fiber on
Prevalence of Cardiovascular Disease
Similar to the T2D component, data for the estimated CVD risk
reduction with higher intakes of dietary ﬁber was derived from
a systematic review and meta-analysis of cohorts by Threapleton
et al. (2013). There, based on a pooled estimate from prospective
studies, consumption of cereal ﬁber intake was found to be
inversely associated with risk of CVD (RR = 0.92 per 7 g per
day, 95% CI 0.84–1.0), equivalent to a 1.1% lower CVD risk per g
cereal ﬁber consumed.
Based on the meta-analytic data from Threapleton et al.
(2013) and InterAct Consortium (2015), our analysis assumed
that for each 1 g increase in dietary cereal ﬁber, incidence of
T2D and CVD would be conservatively decreased by 2.5 and
1.1%, respectively (Table 1). For the purpose of this modeling
exercise, it is assumed that the relative risk reduction of T2D
and CVD per g cereal ﬁber intake corresponds to a decrease in
the population-wide incidence of T2D and CVD of the same
magnitude.
Step 3 of the Cost-of-Illness Analysis:
Estimating the Potential Annual Savings in
Costs Associated with Type 2 Diabetes and
Cardiovascular Disease
Individual consumers are the primary beneﬁciary of any health
improvement following increased consumption of dietary ﬁber.
However, in a publicly funded healthcare system, such as the
system adopted by Canada, more widespread beneﬁts can also
be expected. A reduction in T2D and CVD rates will result
in the diversion of fewer resources to the treatment of these
highly prevalent health conditions. Given a subsequent reduction
in morbidity and mortality that are secondary to improved
dietary habits of the population, society will also beneﬁt from
increased productivity. In this way, although consumers make
deliberate dietary choices, such as increasing ﬁber intake, without
considering the eﬀect on healthcare expenses, the overall impact
of their actions on society can be considerable.
The economic cost of disease in Canada is generally broken
down into direct and indirect categories. Direct costs are those
incurred by the healthcare system with the goal of improving
and/or preventing a patient’s health status from deteriorating.
These usually include hospital care, drug, physician visits, and,
sometimes, other “miscellaneous” costs. Indirect costs, on the
other hand, are commonly known as those incurred by the loss
of productivity to society arising from mortality and morbidity.
A detailed description of the calculations used to determine the
direct and indirect disease costs in Canada can be found in
the EBIC 2005–2008 Report (Public Health Agency of Canada,
2014).
Overview of Type 2 Diabetes Costs
The EBIC 2005–2008 report (Public Health Agency of Canada,
2014) recently provided a comprehensive overview of the cost of
diabetes in Canada. The Statistics Canada Consumer Price Index
(health and personal care sub-index) was used to inﬂate the 2008
estimate of CAD$2.3 billion to 2014 levels and yielded CAD$2.5
billion as the best estimated total direct and indirect economic
costs of T2D (Table 2).
Estimated at CAD$1.3 billion in 2014 dollars, drugs
constituted the largest direct costs of T2D, which includes the
costs of prescribed and non-prescribed medications purchased in
retail stores. Since many diﬀerent medications are used to treat
T2D, it is reasonable that a decrease in the overall incidence
of the disease would subsequently lead to a decrease in T2D
drug-related costs. Hospitalization costs of T2D, estimated at
CAD$527.2 million in 2014 dollars, were calculated on the
basis of bed occupation and aggregated by diagnostic category.
Generally, hospital costs are largely the ﬁxed costs related to
operating and maintaining hospital facilities, as well as the
salaries of the medical professionals and support staﬀ. The
more variable components of hospitalization include the cost
of medications administered to the hospitalized patients, the
cost of food and accommodation, and the cost of diagnostic
procedures carried out in hospitals. A reduction in the incidence
of T2D would be anticipated to lead to fewer hospitalizations
resulting from this disorder and, as a consequence, reductions
in variable costs. Finally, the physician costs were calculated
based on fee-for-service billings submitted to provincial health
insurance plans and are allocated on the basis of the primary
diagnostic category. For example, if a patient visits a physician’s
oﬃce for a follow-up treatment after a ﬁrst diagnosis of T2D,
this cost would be attributed to the cost of T2D. The estimated
cost of T2D-related visits to physicians was approximately
CAD$521.4 million in 2014 dollars. It follows that a reduction
in overall T2D levels will result in fewer doctor visits, which
will reduce these costs. Total indirect costs for T2D were
estimated at CAD$155.4 million in 2014 dollars, including $13.2
million for mortality and $142.2 million for morbidity. In
estimating the mortality costs of T2D, EBIC 2005–2008 report
utilized the friction cost approach, which assumes that sick
and deceased workers can be replaced after a certain period
TABLE 2 | Estimated direct and indirect costs of type 2 diabetes in Canada
(CAD $).
Cost category 2008∗
($millions)
2014†
($millions)
Direct costs
Hospital 492.7 527.2
Physician 487.3 521.4
Drugs 1,198.2 1,282.1
Total direct costs 2,178.2 2,330.7
Indirect costs
Mortality 12.3 13.2
Morbidity 132.9 142.2
Total indirect costs 145.2 155.4
Total costs 2,323.4 2,486.0
∗From the EBIC 2005–2008 report (Public Health Agency of Canada, 2014).
†Current dollars based on adjustments of inflation rates according to Statistics
Canada Consumer Price Index.
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of time known as the ‘friction period.’ Cost estimates of this
method are normally lower than those derived from the classical
human capital method. A reduction in the incidence of T2D is
assumed to lead to decreases in both components of the indirect
costs.
Analysis of Type 2 Diabetes Cost Reduction
The reduction in the cost of T2D was assumed to be linear when
a decline in T2D incidence is observed. The exception was for the
variable costs related to hospitalization. As described earlier, ﬁxed
and variable costs exist in hospitalization. The former is incurred
regardless of the prevalence of any disease, whereas the latter is
largely aﬀected by the number of admissions. A comprehensive
breakdown of hospital care costs in Canada is, to our knowledge,
not available. As a result, it was necessary to approximate the
portion of hospital costs that are ﬁxed and not aﬀected from
reduced incidence of T2D. Previous research has provided a
breakdown of ﬁxed and variable costs in American hospitals
and found that hospital costs are approximately 84% ﬁxed and
16% variable (Roberts et al., 1999). Thus, for the purpose of this
research, it was assumed that a reduction in T2D would not result
in reductions in ﬁxed costs of hospitalization, but would facilitate
a proportional reduction in the variable costs. This means that
each 1% reduction in the incidence of T2D would be followed by
a 0.16% reduction in hospital costs.
It is reasonable to assume that fewer individuals with T2D will
require less medication for treatment. As such, a proportional
reduction was assumed for drug costs. Similarly, given that the
physician care costs are based on physician billings, which are in
turn based on T2D patient visits to doctors’ oﬃces, a reduction
in T2D was assumed to lead to a proportional reduction in T2D-
related physician costs. Finally, as the number of cases with T2D
decreases, costs associated with mortality and morbidity were
assumed to follow in a proportional manner. A summary of
the relationship between T2D incidence and associated costs is
provided in Table 3.
Overview of Cardiovascular Disease Costs
The EBIC 2005–2008 (Public Health Agency of Canada, 2014)
and the NHEX 1975–2013 (Canadian Institute for Health
Information, 2013) expense ﬁgures were both used as the
foundation of the estimates of CVD in this analysis; again
TABLE 3 | Summary of direct and indirect cost reductions that correspond
to a 1% decrease in the incidence of type 2 diabetes.
Cost category % Reduction
Direct costs
Hospital∗ 0.16%
Drugs 1.00%
Physician care 1.00%
Indirect costs
Mortality 1.00%
Morbidity 1.00%
∗Based on the estimation that 16% of hospitalization costs are variable (i.e.,
medications and supplies) and 84% are fixed (i.e., salaries, buildings, and
equipments; Roberts et al., 1999).
with adjustments to 2014 dollars using the Statistics Canada
Consumer Price Index (health and personal care sub-index).
Inﬂating values from the most recent 2008 estimate of CAD$12.2
billion to 2014 dollars yielded a revised valuation of CAD$13.0
billion as the best estimated economic cost of CVD in Canada.
In the case of CVD, the direct costs as presented by the EBIC
2005–2008 report include hospital care, drug, and physician
visits, whereas the indirect costs include mortality and morbidity.
These costs are explained further in the subsections below and
summarized in Table 4.
The largest direct costs associated with CVD were the
hospitalization costs, which were estimated at slightly more
than CAD$5.4 billion in 2014 dollars. Again, the ﬁxed costs
associate with operating hospital facilities and the staﬀ salaries,
while the variable costs associate with drugs administered to the
hospitalized patients, food, and diagnostic procedures. Similar
to T2D estimates, only the variable costs are expected to
decrease with fewer hospitalizations resulting from reductions
in the incidence of CVD. Prescribed drug costs of CVD were
estimated at CAD$4.6 billion in 2014 dollars and, similar to
the T2D estimates, are logically expected to decrease with better
management of the disease. The physician care costs were
CAD$2.5 billion in 2014 dollars and, similar to the drug costs, are
expected to decrease with fewer physician visits when CVD rates
decrease. Finally, the “other direct costs” associated with CVD
were estimated at CAD$143.5 million in 2014 dollars and are
based on estimates of services of other health professionals (e.g.,
physiotherapists), public health, administration, and ambulance
services from the NHEX 1975–2013 report (Canadian Institute
for Health Information, 2013). A reduction in CVD will reduce
TABLE 4 | Estimated direct and indirect costs of cardiovascular disease in
Canada (CAD $).
Cost category 2008∗
($millions)
2014†
($millions)
Direct costs
Hospital 5,068.0 5,422.8
Drugs 4,272.7 4,571.8
Physician care 2,352.0 2,516.6
Other direct‡ 134.1 143.5
Total direct costs 11,826.8 12,654.7
Indirect costs
Mortality 92.4 98.9
Morbidity 269.6 288.5
Total indirect costs 362.0 387.3
Total costs 12,188.8 13,042.0
∗From the EBIC 2005–2008 report (Public Health Agency of Canada, 2014).
†Current dollars based on adjustments of inflation rates according to Statistics
Canada Consumer Price Index. ‡Represents cost estimates for Other Professionals
(chiropractors, physiotherapists, private duty nurses, etc.) and Other Health
Spending (home care, medical transportation, etc.) by the National Health
Expenditure Trends 1975–2013 report (Canadian Institute for Health Information,
2013) where total Other Direct costs for all diseases in 2008 reached CAD$53.0
billion. Percentage of CVD relative to total Other Direct costs within the EBIC 1998
report (Public Health Agency of Canada, 1998) of 0.3% was used to estimate the
2008’s CVD-related other direct economic valuation of CAD$134.1 million and then
adjust it to a 2014 estimate of CAD$143.5 million.
Frontiers in Pharmacology | www.frontiersin.org 5 August 2015 | Volume 6 | Article 167
Abdullah et al. Economic benefits of dietary fiber intake
the demand for some, but not all, of the above-mentioned services
and, as a result, reduces a portion of this component of direct
costs.
In estimating the CVD-related mortality costs of CAD$98.9
million in 2014 dollars, similar to the analysis for T2D by
EBIC 2005–2008, these costs were derived using the friction
cost approach. It is logical that a reduction in the incidence
of CVD and the corresponding decrease in mortality will
reduce this cost. Morbidity, or disability, costs arise when
productivity is lost due to illness for a period of time. The
estimated economic burden of morbidity resulting from CVD
in the EBIC 2005–2008 report was CAD$288.5 million in
2014 dollars. Akin to the mortality component, morbidly costs
are expected to decrease with a reduction in the incidence
of CVD.
Analysis of Cardiovascular Disease Cost Reduction
Similar to the T2D cost reduction, with lower CVD rates,
our CVD cost reduction analysis assumed a proportional
reduction in the variable (but not the ﬁxed) hospitalization
costs, drug costs, and physician costs (Table 5). Unlike the
previous report in Public Health Agency of Canada (1998), the
new EBIC 2005–2008 report does not provide cost estimates
for services by “other health providers” for CVD, which
necessitated estimations using ﬁgures from the NHEX 1973–
2013 and EBIC 1998 reports as previously described. The
costs for “Other” (5.4%), within the “Other Professionals”
category (Canadian Institute for Health Information, 2013),
which includes chiropractors, physiotherapists, private duty
nurses, and others, were expected to be reduced in a manner
proportional to the overall CVD reduction. Similarly, costs that
will likely be reduced by a reduction in CVD include home care,
medical transportation, training of health workers, and others
(13.8%) within the NHEX “Other Health Spending” category.
The ﬁnal result was that a 1% decrease in the incidence of CVD
will result in a 0.19% reduction in other direct CVD-related
costs.
TABLE 5 | Summary of direct and indirect cost reductions that correspond
to a 1% decrease in the incidence of cardiovascular disease.
Cost category % Reduction
Direct costs
Hospital∗ 0.16%
Drugs 1.00%
Physician care 1.00%
Other direct† 0.19%
Indirect costs
Mortality 1.00%
Morbidity 1.00%
∗Based on the estimation that 16% of hospitalization costs are variable (i.e.,
medications and supplies) and 84% are fixed (i.e., salaries, buildings, and
equipments; Roberts et al., 1999). †Based on total disease cost by the EBIC
2005–2008 report (Public Health Agency of Canada, 2014) and estimates from
the National Health Expenditure Trends 1975–2013 report (Canadian Institute for
Health Information, 2013) for Other Professionals (5.4%) and Other Healthcare
Spending (13.8%) categories.
Finally, also similar to the T2D case, morbidity and mortality
costs were assumed to have a directly proportional CVD-
reduction to cost-reduction relationship. Basically, since the
incidence of CVDwill decrease, it is a reasonable assumption that
a proportional reduction in the deaths and disability from CVD
will be observed. As a consequence, the loss of human capital
that would ordinarily be incurred from CVD-related death and
disability does occur and this facilitates an economic beneﬁt.
Results
Tables 6 and 7 summarize the potential T2D and CVD direct
and indirect cost savings when current levels of ﬁber intake
(19.1 g per day for men and 15.6 g per day for women;
Belanger et al., 2014) are increased with cereal ﬁber to levels
that correspond to the IOM’s recommended adequate intakes.
Under the universal fortiﬁcation scenario, assuming a 100%
success rate and maximum potential of economic savings over
the very long run, our analysis predicted total annual healthcare
and related savings of CAD$718.8 million for T2D and $1.3
billion for CVD costs. The optimistic scenario, which assumed
a 50% success rate and medium- to short-term savings, on
the other hand, predicted savings of CAD$359.4 million for
T2D and $647.8 million for CVD costs annually. With a 15%
success rate and a less positive, yet still practical, short- to
TABLE 6 | Potential savings in type 2 diabetes costs among Canadian
adults from improved intake of dietary cereal fiber (CAD $million).
Scenario
Cost category Universal Optimistic Pessimistic Very
pessimistic
Direct cost savings
Hospital 29.7 14.8 4.5 1.5
Physician 183.4 91.7 27.5 9.2
Drugs 451.0 225.5 67.7 22.6
Total direct
cost savings
664.1 332.1 99.6 33.2
Indirect cost savings
Mortality 4.6 2.3 0.7 0.2
Morbidity 50.0 25.0 7.5 2.5
Total indirect
cost savings
54.7 27.3 8.2 2.7
Total cost
savings
718.8 359.4 107.8 35.9
Data represent T2D-related economic savings from the utilization of cereal fiber
for increasing dietary fiber consumption from current levels (Table 1) to levels
that correspond to the IOM’s adequate intake cut-offs, estimated at 38 g per
day for men and 25 g per day for women (Institute of Medicine, 2002). The
universal fortification represents the best-case scenario of potential cost savings if
all Canadian adults (≥18 years of age) were to consume the adequate quantities of
dietary fiber. The optimistic scenario is a medium- to short-term pragmatic estimate
of the potential cost savings when 50% of adults increase intakes of dietary fiber.
The pessimistic scenario is a practical short- to medium-term estimate of cost
savings that could follow the increase in dietary cereal fiber intakes among 15%
of adults. The very pessimistic scenario represents the worst-case estimate when
up to 5% of adults make the dietary change.
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TABLE 7 | Potential savings in cardiovascular disease costs among
Canadian adults from improved intake of dietary cereal fiber (CAD
$million).
Scenario
Cost
Category
Universal Optimistic Pessimistic Very
pessimistic
Direct cost savings
Hospital 134.3 67.2 20.1 6.7
Drugs 707.7 353.8 106.1 35.4
Physician care 389.5 194.8 58.4 19.5
Other direct 4.2 2.1 0.6 0.2
Total direct
cost savings
1,235.7 617.9 185.4 61.8
Indirect cost savings
Mortality 15.3 7.7 2.3 0.8
Morbidity 44.7 22.3 6.7 2.2
Total indirect
cost savings
60.0 30.0 9.0 3.0
Total cost
savings
1,295.7 647.8 194.4 64.8
Data represent CVD-related healthcare savings from the utilization of cereal fiber
for increasing dietary fiber consumption from current levels (Table 1) to levels
that correspond to the IOM’s adequate intake cut-offs, estimated at 38 g per
day for men and 25 g per day for women (Institute of Medicine, 2002). The
universal fortification represents the best-case scenario of potential cost savings if
all Canadian adults (≥18 years of age) were to consume the adequate quantities of
dietary fiber. The optimistic scenario is a medium- to short-term pragmatic estimate
of the potential cost savings when 50% of adults increase intakes of dietary fiber.
The pessimistic scenario is a practical short- to medium-term estimate of cost
savings that could follow the increase in dietary cereal fiber intakes among 15%
of adults. The very pessimistic scenario represents the worst-case estimate when
up to 5% of adults make the dietary change.
medium-term eﬀects, the pessimistic scenario showed savings
of CAD$107.8 million for T2D and $194.4 million for CVD
costs. Finally, the very pessimistic scenario that assumed a
worst-case estimate of a 5% success rate suggested total annual
savings of CAD$35.9 million for T2D and $64.8 million for CVD
costs.
Potential T2D and CVD cost savings with each 1 g per day
increase in dietary cereal ﬁber intake are presented in Tables 8
and 9, respectively. There, given predicted worst-to-best case
scenarios, total annual cost savings ranged between CAD$2.6 and
$51.1 million for T2D, and $4.6 and $92.1 million for CVD.
Summarized in Tables 10 and 11 are the predicted economic
savings when cereal ﬁber was used to incrementally increase
Canadian adult’s current dietary ﬁber intakes to 20, 25, 30, and
35 g per day for men and women alike. For T2D, the very
pessimistic, pessimistic, optimistic, and universal scenarios’ total
savings ranged from CAD$6.8 to $45.2 million, $20.5 to $135.5
million, $68.4 to $451.5 million, and $136.8 to $903.0 million,
respectively (Table 10). Likewise, savings in CVD healthcare
and related costs were estimated to range between CAD$12.3
and $81.4 million (very pessimistic), $37.0 and $244.2 million
(pessimistic), $123.3 and $813.9 million (optimistic), and $246.7
million and $1.6 billion (universal) with increasing the current
ﬁber intakes of Canadian adults to 20, 25, 30, and 35 g per day,
respectively (Table 11).
TABLE 8 | Potential savings in type 2 diabetes cost among Canadian
adults for each 1 g per day increase in intakes of dietary cereal fiber (CAD
$million).
Scenario
Cost category Universal Optimistic Pessimistic Very
pessimistic
Direct cost savings
Hospital 2.1 1.1 0.3 0.1
Physician 13.0 6.5 2.0 0.7
Drugs 32.1 16.0 4.8 1.6
Total direct
cost savings
47.2 23.6 7.1 2.4
Indirect cost savings
Mortality 0.3 0.2 0.1 0.0
Morbidity 3.6 1.8 0.5 0.2
Total indirect
cost savings
3.9 1.9 0.6 0.2
Total cost
savings
51.1 25.5 7.7 2.6
The universal fortification represents the best-case scenario of potential cost
savings in all Canadian adults (≥18 years of age). The optimistic scenario is a
medium- to short-term pragmatic estimate of the potential cost savings in 50%
of adults. The pessimistic scenario is a practical short- to medium-term estimate
of cost savings that could follow the 1 g per day increase in dietary cereal fiber
intakes among 15% of adults. The very pessimistic scenario represents the worst-
case estimate when up to 5% of adults increase their dietary cereal fiber intakes by
1 g per day.
Discussion
Using a cost-of-illness analysis, this study assessed the potential
savings in costs of T2D and CVDwithin the Canadian healthcare
system following higher intakes of dietary cereal ﬁber among
adults. The potential economic beneﬁts that resulted from
improved intake of cereal ﬁber were signiﬁcant. Speciﬁcally, if
between 5 and 100% of the Canadian adults were to utilize
cereal ﬁber to adopt intakes of dietary ﬁber that correspond to
the IOM’s adequate intake levels (Institute of Medicine, 2002),
approximately CAD$36 to $720 million and CAD$65 million to
$1.3 billion would accrue as total annual savings in healthcare and
related costs associated with T2D and CVD, respectively. These
savings are substantial relative to the current healthcare budget
in Canada.
The rising costs of healthcare are a growing concern, especially
in Canada where direct costs of treating disease are borne largely
by an increasingly aging public. Any opportunity to reduce these
costs should be fully studied. The health beneﬁts of increased
dietary ﬁber intakes are well-recognized. Accumulating evidence
suggests protection against a range of major public health
concerns, including diabetes (Murtaugh et al., 2003; Schulze et al.,
2007), CVD (Liu et al., 1999; Pereira et al., 2004), obesity (Liu
et al., 2003), cancers (Aune et al., 2011, 2012), and gastrointestinal
disorders (Petruzziello et al., 2006), all of which place substantial
burdens on healthcare resources in Canada and, likewise, around
the globe. Still, very little knowledge is available on the economic
beneﬁts of greater habitual or recommended intakes of ﬁber. We
are unaware of other economic analyses that have previously
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TABLE 9 | Potential cardiovascular disease cost savings among Canadian
adults for each 1 g per day increase in intakes of dietary cereal fiber (CAD
$million).
Scenario
Cost category Universal Optimistic Pessimistic Very
pessimistic
Direct cost savings
Hospital 9.5 4.8 1.4 0.5
Drugs 50.3 25.1 7.5 2.5
Physician care 27.7 13.8 4.2 1.4
Other direct 0.3 0.1 0.0 0.0
Total direct
cost savings
87.8 43.9 13.2 4.4
Indirect cost savings
Mortality 1.1 0.5 0.2 0.1
Morbidity 3.2 1.6 0.5 0.2
Total indirect
cost savings
4.3 2.1 0.6 0.2
Total cost
savings
92.1 46.0 13.8 4.6
The universal fortification represents the best-case scenario of potential cost
savings in all Canadian adults (≥18 years of age). The optimistic scenario is a
medium- to short-term pragmatic estimate of the potential cost savings in 50%
of adults. The pessimistic scenario is a practical short- to medium-term estimate
of cost savings that could follow the 1 g per day increase in cereal dietary fiber
intakes among 15% of adults. The very pessimistic scenario represents the worst-
case estimate when up to 5% of adults increase their dietary cereal fiber intakes by
1 g per day.
TABLE 10 | Summary of potential total savings in type 2 diabetes costs
among Canadian adults with incremental increases in intakes of dietary
cereal fiber (CAD $million).
20 g per
day
25 g per
day
30 g per
day
35 g per
day
Universal 136.8 392.2 647.6 903.0
Optimistic 68.4 196.1 323.8 451.5
Pessimistic 20.5 58.8 97.1 135.5
Very pessimistic 6.8 19.6 32.4 45.2
Based on differences from current intakes of dietary fiber (Table 1), the universal
fortification represents the best-case scenario of potential cost savings if all
Canadian adults (≥18 years of age) were to use cereal fiber to increase daily fiber
intakes to 20, 25, 30, or 35 g per day for men and women. The optimistic scenario
is a medium- to short-term pragmatic estimate of the potential cost savings when
50% of adults adopt the incremental increases in intakes of dietary fiber. The
pessimistic scenario is a practical short- to medium-term estimate of cost savings
that could follow the incremental increases in dietary fiber intakes among 15% of
adults. The very pessimistic scenario represents the worst-case estimate when up
to 5% of adults make the dietary changes.
assessed the potential savings in T2D- and CVD-related costs
when dietary ﬁber consumption is increased. Although, a few
recent studies have reported the valuable eﬀects of increased ﬁber
intakes on healthcare costs for functional constipation in the US
(Schmier et al., 2014) and Europe (Schmier et al., 2015).
Clinical and epidemiological research continues to delineate
the beneﬁts of foods and nutrients with respect to general
health as well as reduced risk of chronic disease. Such data are
useful for developing and adjusting dietary recommendations.
TABLE 11 | Summary of potential total savings in cardiovascular disease
costs among Canadian adults with incremental increases in intakes of
dietary cereal fiber (CAD $million).
20 g per
day
25 g per
day
30 g per
day
35 g per
day
Universal 246.7 707.0 1,167.4 1,627.8
Optimistic 123.3 353.5 583.7 813.9
Pessimistic 37.0 106.1 175.1 244.2
Very pessimistic 12.3 35.4 58.4 81.4
Based on differences from current intakes of dietary fiber (Table 1), the universal
fortification represents the best-case scenario of potential cost savings if all
Canadian adults (≥18 years of age) were to use cereal fiber to increase daily fiber
intakes to 20, 25, 30, or 35 g per day for men and women. The optimistic scenario
is a medium- to short-term pragmatic estimate of the potential cost savings when
50% of adults adopt the incremental increases in intakes of dietary fiber. The
pessimistic scenario is a practical short- to medium-term estimate of cost savings
that could follow the incremental increases in dietary fiber intakes among 15% of
adults. The very pessimistic scenario represents the worst-case estimate when up
to 5% of adults make the dietary changes.
Given that the deﬁnition of dietary ﬁber is broad in scope
and can include indigestible carbohydrate from a variety of
dietary sources (Health Canada, 2012a), it is reasonable that
diﬀerent ﬁbers from diverse foods impose unique health beneﬁts.
Based on supportive data from published risk analyses, this
economic valuation focused on cereal ﬁber as ameans of reducing
future incidence of T2D and CVD. It is important to note,
however, that this analysis does not support a reductionist
approach to healthful diets; where cereal ﬁber is identiﬁed as
the only ﬁber that can facilitate health and economic beneﬁts.
For example, while cereal ﬁbers are eﬃcacious for decreased
T2D and CVD risk, other ﬁbers, and the foods containing them,
such as fruits and vegetables, are widely accepted as part of
healthy diet. Accordingly, this analysis modeled the addition
of cereal ﬁber to current ﬁber intakes (19.1 g for men and
15.6 g for women), which recognizes a baseline dietary ﬁber
consumption from various dietary sources. This study does
support, however, that health as well as economic beneﬁts could
arise if Canadians impose more healthful lifestyles. From this
and other nutritional economic data (McCarron and Heaney,
2004; Dall et al., 2009; Bibbins-Domingo et al., 2010; Gyles et al.,
2010; Schmier et al., 2014, 2015), it is logical that as healthy
lifestyle habits compound, societal beneﬁts will also grow in
parallel.
For T2D and CVD, results from this study complement
those from Schmier et al. (2014, 2015) and highlight the
importance of communicating such health beneﬁts of dietary
ﬁber to the general public and various stakeholders. For the
food industry, emphasis on the provision of higher-ﬁber foods
could help facilitate a national economic beneﬁt. Government
and healthcare professionals are crucial for implementing
strategies that capitalize on potential success of realizing any
economic savings from increasing ﬁber consumption in Canada.
Policy makers will need to set clear guidelines that facilitate
a high degree of utility for consumers by setting guardrails
around the type(s) of health claims permitted that ensure
consistent and credible message is received by consumers. Finally,
educators and healthcare providers will play a crucial role in
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emphasizing the importance of dietary ﬁber to patients and the
public.
While this cost-of-illness analysis demonstrated the potential
for substantial healthcare savings with increased consumption of
cereal ﬁber, it is reasonable that there would be costs associated
with the implementation of initiatives that impose such dietary
changes for Canadians. These costs would majorly be incurred by
two of the aforementioned stakeholders: government(s) and the
consumer. Government spending would manifest as programs
that promote the consumption foods that impact the Canadian
healthcare economic landscape, such as dietary sources of cereal
ﬁber. Initiatives could include increased emphasis for cereal-
derived ﬁber within current programs such as Canada’s Food
Guide (Health Canada, 2011) as well as independent marketing
campaigns. As a partnership with the food industry, the latter
strategy has been utilized to increase Canadians’ awareness
and use of the Nutrient Facts Table on Canadian food labels
(Government of Canada, 2015). While new and refreshed
programs would be of value for heightening dietary awareness
of foods that could impact healthcare costs, governments and
regulatory agencies across jurisdictions, including Canada, have
already implemented a regulatory framework that promote
the consumption of speciﬁc cereal ﬁbers that are directly
linked with reduced risk factors for CVD. For example, Health
Canada, The Food and Drug Administration, The European
Commission, and Food Standards Australia New Zealand permit
front-of-pack health claims on foods that communicate the
presence of deﬁned threshold levels of oat or barley-derived
beta-glucan and their ability to lower circulating cholesterol
levels (Health Canada, 2010, 2012b; European Commission,
2011, 2012; Food and Drug Administration, 2013; Zealand
FSAN, 2014). Perhaps, further funding allocation is required
to bring increased awareness to speciﬁc health claims in
market, as well as increased use of sources of cereal ﬁber by
industry.
For the second stakeholder, the consumer, the most signiﬁcant
costs incurred would be those required for imposing dietary
change. While this analysis provided cost savings per g increase
in cereal ﬁber consumption, it is ideal if increased consumption
of cereal ﬁber among Canadians surpassed one g per day. That
being said, within Canada and other regions, foods with cereal
ﬁber are ubiquitous within the food supply as foods with whole
grain and/or added bran. Moreover, dietary recommendations
across jurisdictions promote the consumption of whole grains,
which are sources of cereal ﬁber (United States Department of
Agriculture, 2010; Health Canada, 2011; Australian Government,
2013). Whole grains are also primary components of healthful
traditional diets such as the Mediterranean and Nordic Diet
(Jensen and Poulsen, 2013; Gerber and Hoﬀman, 2015). For
some consumers, there could be a cost to consuming a
healthier diet that incorporates eﬃcacious increases in speciﬁc
nutrients such as dietary cereal ﬁber (Jensen and Poulsen,
2013). However, when the biological need to consume food is
combined with minimal consumption of foods or constituents
that counteract the health beneﬁts of cereal ﬁber, these costs
to the consumer would be marginal; and align with the
costs realized if the populace fully embraced regional dietary
guidance from governments, dietitians, and other healthcare
practitioners.
In addition to government and consumers, industry is also
a critical stakeholder for facilitating dietary changes among
Canadians, including increased consumption of cereal ﬁber.
Given that it is the food industry that manufactures and supplies
a signiﬁcant proportion of the foods that comprise the diets of
Canadians, it is reasonable that increased demand for sources
of dietary cereal ﬁber would also incur an upfront cost to
industry. These costs would come from new product innovation,
renovation of existing products, manufacturing, shipping, listing
fees, and marketing. While upfront costs to the food industry
are realized, strong demand for nutritious food with cereal
ﬁber will drive continued support for the development of foods
that contain whole grains and/or added bran. Governments
already impose regulations that outline thresholds regarding
the minimum levels of dietary ﬁber required to make “source
of ﬁber” claims of varying magnitude (European Commission,
2006; Zealand FSAN, 2014; The Canadian Food Inspection
Agency, 2015). Meeting these threshold levels is crucial for
permitting industry to communicate healthful food attributes
to the Consumer. In addition to artisan or unprocessed foods
that contain ﬁber from cereal grains, epidemiological studies that
demonstrate an inverse association between cereal ﬁber and risk
of diabetes, CVD, and mortality include foods manufactured by
the food industry, such as ﬁber-containing ready-to-eat cereals
(Cho et al., 2013; Huang et al., 2015). Continued emphasis from
nutrition leaders in the private and public sectors as well as food
innovation that facilitates widespread consumption of foods with
eﬃcacious levels of cereal ﬁber will be critical for widespread
healthcare cost savings from dietary change.
As discussed previously, to our knowledge, this work is the
ﬁrst to examine the potential savings in costs to the Canadian
healthcare system attributed to higher intakes of dietary ﬁber
manifesting in lower rates of T2D and CVD.We utilized the most
recent literature and national databases for ﬁndings pertaining
to identiﬁcation of the consumer trends and healthcare costs.
Developing three sets of analyses enabled the prediction of
healthcare cost savings that are mostly communicable to policy
makers, dietitians, and other healthcare providers. For example,
while IOM target levels of ﬁber intakes are likely most beneﬁcial
for government policy makers and healthcare associations that
set guidelines for clinical practice, incremental targets are mainly
beneﬁcial to the general public and healthcare practitioners
who focus on a stepwise approach for assisting patients with
increasing ﬁber consumption.
This study also has limitations. Estimates of risk reduction
per g cereal ﬁber were derived from studies that gave prescribed
levels of cereal ﬁber. Thus, it was assumed that the relationship
between cereal ﬁber dose and risk reduction was linear. However,
in some cases a linear dose eﬀect may not exist across all levels
of cereal ﬁber consumed; and, in those instances, thresholds for
cereal ﬁber intake must be met for increased risk reduction.
Recently, data from the InterAct Consortium demonstrated that
an inverse eﬀect of cereal ﬁber on T2D risk was linear with a
steeper slope at >10 g/day (InterAct Consortium, 2015). That
being said, the cost-of-illness analysis in this study utilized
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conservative estimates of risk reduction that were generated
from meta-analyses and were assumed to be constant across all
dosages of cereal ﬁber. Moreover, ﬁber-containing foods that are
recommended by healthcare practitioners and dietary guidelines
typically contain substantial levels of dietary ﬁber that would
assist consumers in consuming >1 g cereal ﬁber per serving and
per day.
Another limitation of the present work may relate to the
fact that isolating the reported health beneﬁts of dietary cereal
ﬁber intakes from other associated lifestyle and environmental
factors is diﬃcult. Fiber intake from certain sources, such as fruits
and vegetables, usually associates with better socio-economic
status (Dubowitz et al., 2008; Boylan et al., 2011), such as
higher education and income, thus possibly healthier overall
environments. To what extent these other lifestyle factors that
associate with higher ﬁber intakes serve as confounders in our
model remains to be assessed.
Conclusion
Given the economic burden of T2D and CVD in Canada and
worldwide, the novel ﬁndings of this analysis shed light on the
economic valuation of optimal dietary ﬁber intakes and reach
beyond the well-established direct health beneﬁts. Strategies to
increase the consumers’ general knowledge of the recommended
intakes of dietary ﬁber, and beneﬁts of cereal ﬁber, as part of
healthy diet and overall lifestyle, and to facilitate stakeholder
synergy, are highly warranted. Ultimately, such evidence-based
strategies are expected to enable better management of healthcare
and related costs associated with T2D and CVD.
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